PGENPRECIGEN, INC.vs its industry peers
A metric-by-metric comparison of PRECIGEN, INC. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PGEN본 종목 | $2.8B#8 | — | 63.5x#16 | 285.6x#8 | 146.7%#2 | -98.6%#14 | -1141.1%#7 | -575.1%#16 | -91.2%#10 | — | 102.8%#6 | — |
| ELVN | $3.7B#1 | — | 4.1x#6 | — | — | -16.5%#5 | — | -11.6%#6 | — | — | 165.6%#4 | — |
| OGN | $3.6B#2 | 17.5x#2 | 3.6x#3 | 0.6x#1 | -2.9%#7 | -78.4%#11 | 14.9%#2 | 18.6%#1 | 4.9%#2 | 5#1 | 34.1%#10 | 2.5%#1 |
| VKTX | $3.5B#3 | — | 8.5x#14 | — | — | -227.1%#16 | — | -88.1%#15 | — | — | 28.5%#12 | — |
| DYN | $3.3B#4 | — | 4.7x#8 | — | — | -40.6%#10 | — | -0.0%#3 | -1301.5%#12 | — | 34.9%#9 | — |
| RCUS | $3.3B#5 | — | 7.1x#12 | 99.9x#7 | -35.3%#9 | -24.7%#6 | -1169.7%#8 | -76.1%#14 | -93.0%#11 | — | 115.3%#5 | — |
| ARQT | $3.1B#7 | 111.4x#3 | 14.0x#15 | 8.2x#4 | 91.3%#3 | 88.5%#1 | -3.3%#3 | -7.3%#5 | -4.1%#3 | — | 43.0%#7 | — |
| MBX | $3.1B#6 | — | 7.5x#13 | — | — | -40.5%#9 | — | -21.2%#7 | — | — | 542.9%#1 | — |
| IMNM | $2.7B#9 | — | 5.2x#9 | 394.5x#9 | -23.2%#8 | 27.5%#2 | -3228.8%#9 | -40.4%#10 | -72.8%#9 | — | 168.6%#3 | — |
| IRON | $2.7B#10 | — | 4.1x#5 | — | — | -94.0%#12 | — | -32.9%#9 | -39.0%#5 | — | 13.5%#14 | — |
| NRIX | $2.7B#11 | — | 6.6x#11 | 31.6x#5 | 54.0%#4 | -36.6%#8 | -340.2%#5 | -65.7%#12 | — | — | 198.1%#2 | — |
| SUPN | $2.5B#13 | — | 2.4x#1 | 3.5x#3 | 8.6%#6 | -152.2%#15 | -8.7%#4 | -3.7%#4 | -5.0%#4 | — | -4.0%#15 | — |
| MLYS | $2.5B#12 | — | 4.5x#7 | — | — | 13.0%#3 | — | -28.1%#8 | -41.3%#6 | — | -24.1%#16 | — |
| VRDN | $2.5B#14 | — | 3.7x#4 | 34.9x#6 | 23359.9%#1 | -26.9%#7 | -512.9%#6 | -51.7%#11 | -54.5%#7 | — | 17.3%#13 | — |
| HRMY | $2.5B#15 | 13.7x#1 | 2.5x#2 | 2.8x#2 | 21.5%#5 | 9.1%#4 | 24.0%#1 | 15.9%#2 | 25.5%#1 | 4#2 | 32.2%#11 | — |
| VERA | $2.4B#16 | — | 6.0x#10 | — | — | -96.9%#13 | — | -73.5%#13 | -72.7%#8 | — | 37.2%#8 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice